Phosphorylation of 4E-BP1 in the mammalian brain is not altered by LRRK2 expression or pathogenic mutations.
Mutations in the leucine-rich repeat kinase 2 (LRRK2) gene are a common cause of autosomal dominant familial Parkinson's disease (PD). LRRK2 encodes a multi-domain protein containing GTPase and kinase enzymatic domains. Disease-associated mutations in LRRK2 variably influence enzymatic activity...
Guardado en:
Autores principales: | Alzbeta Trancikova, Adamantios Mamais, Philip J Webber, Klodjan Stafa, Elpida Tsika, Liliane Glauser, Andrew B West, Rina Bandopadhyay, Darren J Moore |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/86049abe11db46db90e2a405b463745d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Fine-mapping, gene expression and splicing analysis of the disease associated LRRK2 locus.
por: Daniah Trabzuni, et al.
Publicado: (2013) -
LRRK2 kinase regulates α-synuclein propagation via RAB35 phosphorylation
por: Eun-Jin Bae, et al.
Publicado: (2018) -
LRRK2 kinase activity is dependent on LRRK2 GTP binding capacity but independent of LRRK2 GTP binding.
por: Jean-Marc Taymans, et al.
Publicado: (2011) -
LRRK2 levels in immune cells are increased in Parkinson’s disease
por: D. A. Cook, et al.
Publicado: (2017) -
Cryo-EM analysis of homodimeric full-length LRRK2 and LRRK1 protein complexes
por: Kushal Sejwal, et al.
Publicado: (2017)